Research Article
CALCRL Gene is a Suitable Prognostic Factor in AML/ETO+ AML Patients
Table 1
Relationship between the expression levels of CALCRL mRNA and basic clinical features.
| Clinical features | CALCRLlow () | CALCRLhigh () | value |
| Gender (male/female) | 18/16 | 22/11 | 0.3702 | Age (year) | 36 (15–58) | 35 (14–57) | 0.8951 | | 14.04 (0.8–79.05) | 21.55 (2.64–200) | 0.2582 | | 74.24 (35–115) | 67.91 (47–135) | 0.2044 | | 28.53 (6–93) | 27.12 (8–89) | 0.7728 | HGB g/L | 46.16 (18–80.5) | 51.65 (13–87) | 0.2575 | Blast in BM (%) | 46.00 (0.4–88) | 50.74 (6.4–88.1) | 0.5086 | Hazard stratification | | | 0.936 | Low risk | 10 | 11 | | Medium risk | 16 | 15 | | High risk | 8 | 7 | |
|
|